Filing Details

Accession Number:
0001062993-22-017738
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-08-11 16:23:37
Reporting Period:
2022-08-09
Accepted Time:
2022-08-11 16:23:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
10795 Becton Dickinson & Co BDX Surgical & Medical Instruments & Apparatus (3841) 220760120
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1621793 Jr E Thomas Polen C/O Becton, Dickinson And Company
1 Becton Drive
Franklin Lakes NJ 07417
Executive Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-08-09 3,825 $147.68 32,703 No 4 M Direct
Common Stock Disposition 2022-08-09 2,173 $260.00 30,530 No 4 D Direct
Common Stock Disposition 2022-08-09 1,652 $260.00 28,878 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 D Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Appreciation Rights Disposition 2022-08-09 3,825 $0.00 3,825 $147.68
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2016-11-25 2025-11-25 No 4 M Direct
Footnotes
  1. The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $260.00 through $260.03. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. This transaction was made pursuant to a 10b5-1 plan entered into on May 12, 2022.
  2. Direct holdings reflect adjustments made in connection with the spin-off of Embecta Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person.
  3. Award terms reflect adjustments made in connection with the spin-off of Embecta Corp.
  4. The stock appreciation rights vest in four annual installments beginning November 26, 2016.